RealTalk MS Reaches a Milestone :26
Join the RealTalk MS Conversation :48
Living with MS? Your Access to Healthcare is Under Attack …Again! 2:53
Mavenclad Receives FDA Approval for Treating Relapsing-Remitting and Active Secondary Progressive MS 11:37
Siponimod Receives FDA Approval for Treating Relapsing-Remitting and Active Secondary Progressive MS 15:01
Celgene Submits Application for FDA Approval of Ozanimod for Treating Relapsing-Remitting MS 16:41
My Interview with Dr. Valerie Block 19:16
Download the Free RealTalk MS App 34:04
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes.
Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Phone: (310) 526-2283
RealTalk MS Episode 84
Hosted By: Jon Strum
Guest: Dr. Valerie Block
Tags: MS, MultipleSclerosis, MSResearch, ProgressiveMS, Mavenclad, EMDSerono, Siponimod, Novartis, Celgene, RealTalkMS